9
Views
27
CrossRef citations to date
0
Altmetric
Transcriptional Regulation

LyF-1, a Transcriptional Regulator That Interacts with a Novel Class of Promoters for Lymphocyte-Specific Genes

, &
Pages 5229-5243 | Received 14 May 1991, Accepted 19 Jul 1991, Published online: 31 Mar 2023

References

  • Abramson, S., R. G. Miller, and R. A. Phillips. 1977. The identification in adult bone marrow of pluripotent and restricted stem cells of the myeloid and lymphoid systems. J. Exp. Med. 145:1567-1579.
  • Araki, K., H. Maeda, J. Wang, D. Kitamura, and T. Watanabe. 1988. Purification of a nuclear trans-acting factor involved in the regulated transcription of a human immunoglobulin heavy chain gene. Cell 53:723-730.
  • Baeuerle, P., and D. Baltimore. 1988. Activation of DNA- binding activity in an apparently cytoplasmic precursor of the NF-kB transcription factor. Cell 53:211-217.
  • Baeuerle, P., and D. Baltimore. 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science 242:540-546.
  • Blackwell, T. K., and F. W. Alt. 1988. Immunoglobulin genes, p. 1-60. In B. D. Hames and D. M. Glover (ed.), Molecular immunology. IRL Press, Washington, D.C.
  • Bollum, F. J. 1979. Terminal deoxynucleotidyl transferase as a hematopoietic cell marker. Blood 54:1203-1215.
  • Boyes, J., and A. Bird. 1991. DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell 64:1123-1134.
  • Braun, T., G. Buschhausen-Denker, E. Bober, E. Tannich, and H. H. Arnold. 1989. A novel human muscle factor related to but distinct from MyoDl induces myogeneic conversion in 10T1/2 fibroblasts. EMBO J. 8:701-709.
  • Briggs, M. R., J. T. Kadonaga, S. P. Bell, and R. Tjian. 1986. Purification and biochemical characterization of the promoter- specific transcription factor, Spl. Science 234:47-52.
  • Chang, L. M. S. 1971. Development of terminal deoxynucleoti- dyl transferase activity in embryonic calf thymus gland. Bio-chem. Biophys. Res. Commun. 44:124-131.
  • Clevers, H. C., S. Dunlap, T. E. Wileman, and C. Terhorst. 1988. Human CD3-ε gene contains three miniexons and is transcribed from a non-TATA promoter. Proc. Natl. Acad. Sci. USA 85:8156-8160.
  • Davis, R. L., H. Weintraub, and A. B. Lassar. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51:987-1000.
  • Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
  • Edmondson, D. G., and E. N. Olson. 1989. A gene with homology to the myc similarity region of MyoDl is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev. 3:628-640.
  • Ephrussi, A., G. M. Church, S. Tonegawa, and W. Gilbert. 1985. B-lineage-specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science 227:134-140.
  • Evans, T., M. Reitman, and G. Felsenfeld. 1988. An erythrocyte- specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes. Proc. Natl. Acad. Sci. USA 85:5976-5980.
  • Fowlkes, B. J., and D. M. Pardoll. 1989. Molecular and cellular events of T cell development. Adv. Immunol. 44:207-264.
  • Garvin, A. M., S. Pawar, J. D. Marth, and R. M. Perlmutter. 1988. Structure of the murine lck gene and its rearrangement in a murine lymphoma cell line. Mol. Cell. Biol. 8:3058-3064.
  • Ghosh, S., and D. Baltimore. 1990. Activation in vitro of NF-kB by phosphorylation of its inhibitor IkB. Nature (London) 344:678-682.
  • Gierer, A. 1973. Molecular models and combinatorial principles in cell differentiation and morphogenesis. Cold Spring Harbor Symp. Quant. Biol. 38:951-961.
  • Gluzman, Y. 1981. SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23:175-182.
  • Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyl-transferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
  • Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
  • Grosschedl, R., and D. Baltimore. 1985. Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements. Cell 41:885-897.
  • Gunther, C. V., J. A. Nye, R. S. Bryner, and B. J. Graves. 1990. Sequence-specific DNA binding of the proto-oncoprotein ets-1 defines a transcriptional activator sequence within the long terminal repeat of the Moloney murine sarcoma virus. Genes Dev. 4:667-679.
  • Hermanson, G. G., M. Briskin, D. Sigman, and R. Wall. 1989. Immunoglobulin enhancer and promoter motifs 5′ of the B29 B-cell-specific gene. Proc. Natl. Acad. Sci. USA 86:7341-7345.
  • Higuchi, R. 1989. Using PCR to engineer DNA, p. 61-70. In H. A. Erlich (ed.), PCR technology, principles and applications for DNA amplification. Stockton Press, New York.
  • Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell culture. J. Mol. Biol. 26:365-369.
  • Ho, I.-C., N. K. Bhat, L. R. Gottschalk, T. Lindsten, C. B. Thompson, T. S. Papas, and J. M. Leiden. 1990. Sequence-specific binding of human ets-1 to the T cell receptor a gene enhancer. Science 250:814-818.
  • Janossy, G., F. J. Bollum, K. F. Bradstock, A. McMichael, N. Rapson, M. F. Greaves. 1979. Terminal transferase-positive human bone marrow cells exhibit the antigenic phenotype of common acute leukemia. J. Immunol. 123:1525-1529.
  • Jones, K. A., K. R. Yamamoto, and R. Tjian. 1985. Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro. Cell 42:559-572.
  • Jongstra, J., G. F. Tidmarsh, J. Jongstra-Bilen, and M. M. Davis. 1988. A new lymphocyte-specific gene which encodes a putative Ca2+ binding protein is not expressed in transformed T lymphocyte lines. J. Immunol. 141:3999-4004.
  • Kadonaga, J. R., and R. Tjian. 1986. Affinity purification of sequence-specific DNA-binding proteins. Proc. Natl. Acad. Sci. USA 83:5889-5893.
  • Kato, K., H. M. Goncalves, G. E. Gouts, and F. J. Bollum. 1967. Deoxynucleotide-polymerizing enzymes of calf thymus gland. J. Biol. Chem. 242:2780-2789.
  • Klemsz, M. J., S. R. McKercher, A. Celada, C. V. Beveren, and R. A. Maki. 1990. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61:113-124.
  • Koiwai, O., and A. Morita. 1988. Isolation of putative promoter region for human terminal deoxynucleotidyl transferase gene. Biochem. Biophys. Res. Commun. 154:91-100.
  • Koiwai, O., T. Yokota, T. Kageyama, T. Hirose, S. Yoshida, and K. Arai. 1986. Isolation and characterization of bovine and mouse terminal deoxynucleotidyltransferase cDNAs expressible in mammalian cells. Nucleic Acids Res. 14:5777-5792.
  • Kudo, A., and F. Melchers. 1987. A second gene, VpreB in the λ-5 locus of the mouse, which appears to be selectively expressed in pre-B lymphocytes. EMBO J. 6:2267-2272.
  • Kudo, A., N. Sakaguchi, and F. Melchers. 1987. Organization of the murine Ig-related λ-5 gene transcribed selectively in pre-B lymphocytes. EMBO J. 6:103-107.
  • Kung, P. C., A. E. Silverstone, R. P. McCaffrey, and D. Baltimore. 1975. Murine terminal deoxynucleotidyl transferase: cellular distribution and response to cortisone. J. Exp. Med. 141:855-865.
  • Landau, N. R., and D. Baltimore. Unpublished data.
  • Landau, N. R., D. G. Schatz, M. Rosa, and D. Baltimore. 1987. Increased frequency of N-region insertion in a murine pre-B-cell line infected with a terminal deoxynucleotidyl transferase retroviral expression vector. Mol. Cell. Biol. 7:3237-3243.
  • Landau, N. R., T. P. St. John, I. L. Weissman, S. C. Wolf, A. E. Silverstone, and D. Baltimore. 1984. Cloning of terminal transferase cDNA by antibody screening. Proc. Natl. Acad. Sci. USA 81:5836-5840.
  • Landolfi, N. F., J. D. Capra, and P. W. Tucker. 1986. Interaction of cell type-specific nuclear proteins with immunoglobulin VH promoter region sequences. Nature (London) 323:548-551.
  • Lassar, A. B., J. N. Buskin, D. Lockshon, R. L. Davis, S. Apone, S. D. Hauschka, and H. Weintraub. 1989. MyoD is a sequence- specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell 58:823-831.
  • Libermann, T. A., M. Lenardo, and D. Baltimore. 1990. Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression. Mol. Cell. Biol. 10:3155-3162.
  • Loh, D. (Washington University, St. Louis, Mo.). Personal communication.
  • Luria, S., G. Gross, M. Horowitz, and D. Givol. 1987. Promoter and enhancer elements in the rearranged a chain gene of the human T cell receptor. EMBO J. 6:3307-3312.
  • Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
  • Martin, D. I. K., S.-F. Tsai, and S. H. Orkin. 1989. Increased γ-globin expression in a nondeletion HPFH mediated by an erythroid-specific DNA-binding factor. Nature (London) 338:435-438.
  • Maxam, A., and W. Gilbert. 1980. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 65:499-560.
  • McCaffrey, T. P., T. A. Harrison, R. Parkman, and D. Baltimore. 1975. Terminal deoxynucleotidyl transferase activity in human leukemic cells and in normal human thymocytes. N. Engl. J. Med. 292:775-780.
  • McKnight, S. L., and R. Kingsbury. 1982. Transcriptional control signals of a eukaryotic protein-coding gene. Science 217:316-324.
  • Mercola, M., J. Goverman, C. Mirell, and K. Calame. 1985. Immunoglobulin heavy-chain enhancer requires one or more tissue-specific factors. Science 227:266-270.
  • Meyer, K. B., M. J. Sharpe, M. A. Surani, and M. S. Neuberger. 1990. The importance of the 3′-enhancer region in immunoglobulin k gene expression. Nucleic Acids Res. 18:5609-5615.
  • Murre, C., P. S. McCaw, and D. Baltimore. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56:777-783.
  • Nelsen, B., T. Kadesch, and R. Sen. 1990. Complex regulation of the immunoglobulin μ heavy-chain gene enhancer: μB, a new determinant of enhancer function. Mol. Cell. Biol. 10:3145-3154.
  • Oettinger, M. A., D. G. Schatz, C. Gorka, and D. Baltimore. 1990. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248:1517-1523.
  • Omori, S., P. Ernst, K. Lo, and S. T. Smale. Unpublished data.
  • O’Shea-Greenfield, A., and S. T. Smale. Unpublished data.
  • Parker, B. A., and G. R. Stark. 1979. Regulation of simian virus 40 transcription: sensitive analysis of the RNA species present early in infections by virus or viral DNA. J. Virol. 31:360-369.
  • Peterson, R. C., L. C. Cheung, R. J. Mattaliano, S. T. White, L. M. S. Chang, and F. J. Bollum. 1985. Expression of human terminal deoxynucleotidyl transferase in Escherichia coli. J. Biol. Chem. 260:10495-10502.
  • Pillai, S., and D. Baltimore. 1987. Formation of a disulphide- linked μ2ω2 tetramers in pre-B cells by the 18K ω-immunoglob- ulin light chain. Nature (London) 329:172-174.
  • Pongubala, J. M. R., and M. L. Atchison. 1991. Functional characterization of the developmentally controlled immunoglobulin kappa 3′ enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors. Mol. Cell. Biol. 11:1040-1047.
  • Riley, L. K., J. K. Morrow, M. J. Danton, and M. S. Coleman. 1988. Human terminal deoxyribonucleotidyltransferase: molecular cloning and structural analysis of the gene and 5′ flanking region. Proc. Natl. Acad. Sci. USA 85:2489-2493.
  • Ruezinsky, D., H. Beckmann, and T. Kadesch. 1991. Modulation of the IgH enhancer’s cell type specificity through a genetic switch. Genes Dev. 5:29-37.
  • Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
  • Sarin, P. S., and R. C. Gallo. 1974. Terminal deoxynucleotidyltransferase in chronic myelogenous leukemia. J. Biol. Chem. 249:8051-8053.
  • Schatz, D. G., M. A. Oettinger, and D. Baltimore. 1989. The V(D)J recombination activating gene, RAG-1. Cell 59:1035-1048.
  • Sen, R., and D. Baltimore. 1986. Multiple factors interact with the immunoglobulin enhancer sequences. Cell 46:705-716.
  • Sen, R., and D. Baltimore. 1986. Inducibility of κ immunoglobulin enhancer-binding protein NF-kB by a posttranslational mechanism. Cell 47:921-928.
  • Smale, S. T. Unpublished data.
  • Smale, S. T., and D. Baltimore. 1989. The “initiator” as a transcription control element. Cell 57:103-113.
  • Smale, S. T., M. C. Schmidt, A. J. Berk, and D. Baltimore. 1990. Transcriptional activation by Sp1 as directed through TATA or initiator: specific requirement for mammalian transcription factor IID. Proc. Natl. Acad. Sci. USA 87:4509-4513.
  • Smale, S. T., and R. Tjian. 1985. Transcription of herpes simplex virus tk sequences under the control of wild-type and mutant human RNA polymerase I promoters. Mol. Cell. Biol. 5:352-362.
  • Staudt, L., R. G. Clerc, H. Singh, J. G. LeBowitz, P. A. Sharp, and D. Baltimore. 1988. Molecular cloning of a lymphoid- specific cDNA encoding a protein that binds to the regulatory octamer DNA motif. Science 241:577-580.
  • Staudt, L., H. Singh, R. Sen, T. Wirth, P. A. Sharp, and D. Baltimore. 1986. A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature (London) 323:640-643.
  • Takadera, T., S. Leung, A. Gernone, Y. Koga, Y. Takihara, N. G. Miyamoto, and T. W. Mak. 1989. Structure of the two promoters of the human lck gene: differential accumulation of two classes of lck transcripts in T cells. Mol. Cell. Biol. 9:2173-2180.
  • Tanaka, M., U. Grossniklaus, W. Herr, and N. Hernandez. 1988. Activation of the U2 snRNA promoter by the octamer motif defines a new class of RNA polymerase II enhancer elements. Genes Dev. 2:1764-1778.
  • Travis, A., A. Amsterdam, C. Belanger, and R. Grosschedl. 1991. LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain regulates T-cell receptor a enhancer function. Genes Dev. 5:880-894.
  • van den Elsen, P., K. Georgopoulos, B. Shepley, S. Orkin, and C. Terhorst. 1986. Exon/intron organization of the genes coding for the 8 chains of the human and murine T-cell receptor/T3 complex. Proc. Natl. Acad. Sci. USA 83:2944-2948.
  • van de Wetering, M., M. Oosterwegel, D. Dooijes, and H. Clevers. 1991. Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box. EMBO J. 10:123-132.
  • Wall, L., E. deBoer, and F. Grosveld. 1988. The human β-globin gene 3′ enhancer contains multiple binding sites for an eryth- roid-specific protein. Genes Dev. 2:1089-1100.
  • Wall, R. (University of California, Los Angeles). 1991. Personal communication.
  • Waterman, M. L., W. H. Fischer, and K. A. Jones. 1991. A thymus-specific member of the HMG protein family regulates the human T cell receptor Ca enhancer. Genes Dev. 5:656-669.
  • Wirth, T., L. Staudt, and D. Baltimore. 1987. An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity. Nature (London) 329:174-178.
  • Wright, W. E., D. A. Sassoon, and V. K. Lin. 1989. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56:607-617.
  • Wu, A. M., J. E. Till, L. Siminovitch, and E. A. McCulloch. 1968. Cytological evidence for a relationship between normal and hematopoietic colony-forming cells and cells of the lymphoid system. J. Exp. Med. 127:455-463.
  • Zinn, K., D. DiMaio, and T. Maniatis. 1984. Identification of two distinct regulatory regions adjacent to the human β-interferon gene. Cell 34:865-879.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.